Indianapolis, IN, United States of America

David A Boothman

USPTO Granted Patents = 12 


Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 55(Granted Patents)


Location History:

  • Sagamore Hills, OH (US) (2005)
  • Austin, TX (US) (2016)
  • Indianapolis, IN (US) (2020)
  • Dallas, TX (US) (2016 - 2021)

Company Filing History:


Years Active: 2005-2021

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Innovations and Contributions of David A Boothman

Introduction

David A Boothman is a prominent inventor based in Indianapolis, Indiana. He has made significant contributions to the field of polymer chemistry and cancer therapeutics. With a total of 12 patents to his name, Boothman has developed innovative solutions that address critical challenges in medicine and materials science.

Latest Patents

Among his latest patents are groundbreaking inventions such as block copolymer and micelle compositions. These block copolymers consist of a hydrophilic polymer segment and a hydrophobic polymer segment, which can be utilized in various therapeutic and diagnostic applications. Additionally, his work on tumor-selective combination therapy offers promising strategies for selectively targeting different cancer cell types, enhancing the effectiveness of chemotherapeutic treatments.

Career Highlights

Boothman has had a distinguished career, working with esteemed institutions such as the University of Texas System and the University of Illinois. His research has not only advanced scientific understanding but has also paved the way for new treatment modalities in oncology.

Collaborations

Throughout his career, Boothman has collaborated with notable colleagues, including Jinming Gao and Paul Joseph Hergenrother. These partnerships have fostered innovation and contributed to the development of his patented technologies.

Conclusion

David A Boothman exemplifies the spirit of innovation through his extensive work in polymer chemistry and cancer therapy. His contributions continue to impact the scientific community and improve patient outcomes in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…